Home › NDC Lookup › Ingredients › Fexofenadine Hcl And Pseudoephedrine Hci › 43598-0823-35
Fexofenadine HCl and Pseudoephedrine HCI 60 mg; 120 mg Tablet, Extended Release — NDC 43598-0823-35 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Fexofenadine HCl and Pseudoephedrine HCI 60 mg; 120 mg Tablet, Extended Release — NDC 43598-823-35 (Billing 43598-0823-35)

by Dr. Reddy's Laboratories Inc. · 2 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of Fexofenadine HCl and Pseudoephedrine HCI 60 mg; 120 mg Tablet, Extended Release from Dr. Reddy's Laboratories Inc., marketed since Oct 2022 and currently FDA-listed; retail pharmacies pay about $0.4832 per unit (NADAC).

NDC 43598-0823-35
🏷️ FDA NDC (as labeled) 43598-823-35 billing pads the product segment with a zero
This package
Contains5 tablet, extended release in 1 blister pack Cost per ea$0.4832 NADAC Per package$4.83 / 10 tablets Pack sizes4 compare ↓
Product page 43598-0823-14 Also comes in: 5 tablets 43598-823-14 5 tablets 43598-823-31 35 tablets 43598-823-40
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 3, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Past resolved recalls for this product (2)
Class III · Nov 12, 2021 · Terminated — Failed dissolution specifications (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0269-2022
Class III · Nov 12, 2021 · Terminated — Failed dissolution specifications (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0275-2022

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 43598-823-35
Product NDC 43598-823
11-digit billing NDC 43598082335
NCPDP billing unit EA — each (per item)
SPL Set ID 6fd05737-d996-b5b6-dccf-bc179a9d606c
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-10-19
Dosage form TABLET, EXTENDED RELEASE
Substance FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43993002687420
GPI class Fexofenadine-Pseudoephed ER
GCN Seq No 036868
GCN 63565
HICL code 016846
Ingredient (HICL) Fexofenadine/Pseudoephedrine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2O
Therapeutic class — specific (HIC3) 2Nd Gen Antihistamine And Decongestant Combination
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name FEXOFENADINE-PSE ER 60-120 TAB
FDB brand name Fexofenadine-Pse Er
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 036868
  • GCN: 63565
  • GPI-14 (Medi-Span): 43993002687420
  • HICL (First Databank): 016846
  • AHFS class code: 04:08.00.00
Why two NDCs? The FDA registers this code as 43598-823-35 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 43598-0823-35. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name FEXOFENADINE-PSE ER 60-120 TAB Ingredient Fexofenadine/Pseudoephedrine
📗 Our plain-language guide HelloPharmacist
  • It actually tackles two things at once. The fexofenadine part is an antihistamine that helps with allergy symptoms like runny nose, sneezing, itchy and watery eyes, and itching of...
  • What exactly does this medication do — does it just help with allergies?
  • Yes, it really does matter. You should take this tablet on an empty stomach with a full glass of water. Also, use water specifically — do not take it with fruit juice. Taking it wi...
  • Does it matter when I take it — like with food or on an empty stomach?
📖 Read our full Fexofenadine and Pseudoephedrine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.483 $4.83 / 10 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Nov 2021 Sep 2022 Feb 2026 Sep 2026 $0.585 $0.413
▼ Down 15% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
43598-0823-14 43598-823-14 Main listing 4 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.4832 / ea $9.66 2019-07-18 — Active
43598-0823-31 43598-823-31 6 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.4832 / ea $14.50 2019-07-18 — Active
43598-0823-35 You're viewing this 2 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.4832 / ea $4.83 2019-10-31 — Active
43598-0823-40 43598-823-40 35 TABLET, EXTENDED RELEASE in 1 CARTON — — — — Active

This pack effectively ties for the lowest per-ea cost of the 3 priced pack sizes ($0.4832 NADAC).

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 2 blister pack in 1 carton / 5 tablet, extended release in 1 blister pack.
What NDC number is used to bill for this package of Fexofenadine HCl and Pseudoephedrine HCI 60 mg; 120 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mgthis 43598-0823-35 Dr. 5 tablets $0.483 — Availability likely —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 46122-0694-65 AmeriSource 10 tablets $0.483 — Availability likely —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 55111-0447-14 Dr. 5 tablets $0.483 — Availability likely —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-0044-20 Walgreens 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-0094-67 WALGREEN 10 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 00363-1606-20 Walgreens 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-2110-20 walgreens 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00536-1431-07 Rugby 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 11822-0021-04 Rite 5 tablets — — FDA listed —
Allergy and Congestion 60 mg/1; 120 mg 11822-7388-05 Rite 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 30142-0059-84 KROGER 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 30142-0097-20 Kroger 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 30142-0447-14 The 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 30142-0611-14 The 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 37808-0022-31 HEB 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 37808-0999-30 H 30 tablets — — FDA listed —
Allegra-D Allergy and Congestion 60 mg/1; 120 mg 41167-4310-02 Chattem, 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 41415-0995-20 PUBLIX 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 46122-0452-60 AmeriSource 20 tablets — — Discontinued —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 47335-0724-64 Sun 5 tablets — — FDA listed —
Allegra-D 60 mg/1; 120 mg 50090-1203-00 A-S 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51316-0007-67 CVS 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51316-0015-20 CVS 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51660-0037-21 Ohm 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 58602-0807-67 Aurohealth 10 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 59779-0508-14 CVS 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 69842-0973-20 CVS 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 69842-0990-20 CVS 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 70000-0677-01 Cardinal 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 70677-1010-01 Strategic 5 tablets — — FDA listed —
Foster And Thrive Allergy And Congestion D 60 mg/1; 120 mg 70677-1315-01 Strategic 1 tablet — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 79903-0108-20 Wal-mart 5 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Oct 2022
📍
2026
Currently FDA-listed
4 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeCapsule
ImprintR;195
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII SMD1X3XO9M
    Powdered cellulose is a fine, plant-based powder made from purified wood fibers. In medicines, it acts as a filler to add bulk and volume, and helps tablets or capsules hold together during manufacturing and storage.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn starch, croscarmellose sodium, colloidal silicon dioxide, ferric oxide, hypromellose, kollidon SR, magnesium stearate, mannitol, powder cellulose and triethyl citrate.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDr. Reddy's Laboratories Inc.
Labeler code43598
First marketedOct 2022
Product typeDrug For Further Processing
Portfolio160 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 60 words ▾

Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat temporarily relives nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 73 words ▾

Directions do not divide, crush, chew or dissolve the tablet; swallow tablet whole adults and children 12 years of age and over take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

⚠️ Warnings ~1 min read ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have difficulty swallowing Ask a doctor before use if you have heart disease thyroid disease glaucoma high blood pressure diabetes trouble urinating due to an enlarged prostate gland kidney disease.

Your doctor should determine if you need a different dose. When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions) the tablet coating may be seen in the stool (this is normal). Continue to take as directed (see Directions).

Stop use and ask doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever you get nervous, dizzy, or sleepless If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 11 words ▾

Active ingredient(s) Fexofenadine HCl USP, 60 mg Pseudoephedrine HCl USP,120 mg

🧪 Inactive Ingredients 22 words ▾

Inactive ingredients corn starch, croscarmellose sodium, colloidal silicon dioxide, ferric oxide, hypromellose, kollidon SR, magnesium stearate, mannitol, powder cellulose and triethyl citrate.

🎯 Purpose 4 words ▾

Purpose Antihistamine Nasal decongestant

📄 Do Not Use 76 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have difficulty swallowing

📄 Ask a Doctor Before Use If 37 words ▾

Ask a doctor before use if you have heart disease thyroid disease glaucoma high blood pressure diabetes trouble urinating due to an enlarged prostate gland kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 49 words ▾

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions) the tablet coating may be seen in the stool (this is normal). Continue to take as directed (see Directions).

📄 Stop Use and Ask a Doctor If 37 words ▾

Stop use and ask doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever you get nervous, dizzy, or sleepless

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 15 words ▾

Questions? Call 1-888-375-3784 Distributed by: Dr. Reddy’s Laboratories, Inc. Princeton, NJ 08540 Made in India

📄 Package Label / Principal Display Panel 5 words ▾

Principal Display Panel Blister carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
5 tablets43598-0823-14 28 Rx · $485
5 tablets43598-0823-31 No Medicaid data
5 tablets this page43598-0823-35 No Medicaid data
35 tablets43598-0823-40 No Medicaid data
Drug total (last 4 qtrs): 28 Rx · 1,289 units · $485 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Dr. Reddy's Laboratories Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dr. Reddy's Laboratories Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 5 tablets (43598-0823-14), 5 tablets (43598-0823-31), 35 tablets (43598-0823-40). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Dr. Reddy's Laboratories Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 43598-0813-14 · Dr. 43598-0824-18 · Dr.Reddys →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.